NC5A Fundamental Analysis - NORCOM INFORMATION TECHNOLOG

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to NC5A. NC5A was compared to 68 industry peers in the IT Services industry. NC5A has a bad profitability rating. Also its financial health evaluation is rather negative. NC5A has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NC5A has reported negative net income.

In the past year NC5A had a positive cash flow from operations.

In the past 5 years NC5A reported 4 times negative net income.

In multiple years NC5A reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of NC5A (-11.94%) is worse than 82.35% of its industry peers.

With a Return On Equity value of -22.28%, NC5A is not doing good in the industry: 77.94% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-11.94%
ROE	-22.28%
ROIC	N/A

ROA(3y)-10.49%

ROA(5y)-7.8%

ROE(3y)-19.42%

ROE(5y)-14.38%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 46.47%, NC5A is not doing good in the industry: 61.76% of the companies in the same industry are doing better.

In the last couple of years the Gross Margin of NC5A has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for NC5A so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	46.47%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.03%

GM growth 5Y-1.11%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NC5A does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, NC5A has about the same amount of shares outstanding.

The number of shares outstanding for NC5A has been increased compared to 5 years ago.

The debt/assets ratio for NC5A has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.85, we must say that NC5A is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of 0.85, NC5A is not doing good in the industry: 80.88% of the companies in the same industry are doing better.

A Debt/Equity ratio of 0.28 indicates that NC5A is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.28, NC5A is in the better half of the industry, outperforming 67.65% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.28
Debt/FCF	N/A
Altman-Z	0.85

ROIC/WACCN/A

WACC6%

2.3 Liquidity

A Current Ratio of 0.93 indicates that NC5A may have some problems paying its short term obligations.

With a Current ratio value of 0.93, NC5A is not doing good in the industry: 76.47% of the companies in the same industry are doing better.

NC5A has a Quick Ratio of 0.93. This is a bad value and indicates that NC5A is not financially healthy enough and could expect problems in meeting its short term obligations.

NC5A has a worse Quick ratio (0.93) than 67.65% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.93
Quick Ratio	0.93

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NC5A shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.11%.

The Revenue for NC5A has decreased by -17.20% in the past year. This is quite bad

The Revenue has been decreasing by -9.70% on average over the past years.

EPS 1Y (TTM)-12.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-125.08%

Revenue 1Y (TTM)-17.2%

Revenue growth 3Y-9.1%

Revenue growth 5Y-9.7%

Sales Q2Q%-24.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NC5A. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NC5A is valued a bit more expensive than 77.94% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	47.61

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NC5A does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

NORCOM INFORMATION TECHNOLOG

FRA:NC5A (12/29/2025, 7:00:00 PM)

1.575

-0.01 (-0.63%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustryIT Services

Earnings (Last)11-28 2025-11-28

Earnings (Next)04-28 2026-04-28

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners27.42%

Ins Owner ChangeN/A

Market Cap3.35M

Revenue(TTM)6.24M

Net Income(TTM)-623.20K

Analysts82.86

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.54
P/FCF	N/A
P/OCF	8.69
P/B	1.2
P/tB	22.47
EV/EBITDA	47.61

EPS(TTM)-0.3

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.07

FCFYN/A

OCF(TTM)0.18

OCFY11.51%

SpS2.93

BVpS1.31

TBVpS0.07

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-11.94%
ROE	-22.28%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	46.47%
FCFM	N/A

ROA(3y)-10.49%

ROA(5y)-7.8%

ROE(3y)-19.42%

ROE(5y)-14.38%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.03%

GM growth 5Y-1.11%

F-Score5

Asset Turnover1.2

Health

		Industry Rank	Sector Rank
Debt/Equity	0.28
Debt/FCF	N/A
Debt/EBITDA	9.58
Cap/Depr	80.66%
Cap/Sales	8.52%
Interest Coverage	N/A
Cash Conversion	480.95%
Profit Quality	N/A
Current Ratio	0.93
Quick Ratio	0.93
Altman-Z	0.85

F-Score5

WACC6%

ROIC/WACCN/A

Cap/Depr(3y)89.83%

Cap/Depr(5y)101.32%

Cap/Sales(3y)5.87%

Cap/Sales(5y)5.35%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-12.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-125.08%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-17.2%

Revenue growth 3Y-9.1%

Revenue growth 5Y-9.7%

Sales Q2Q%-24.02%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-8.54%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y20.48%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y43.2%

OCF growth 3YN/A

OCF growth 5YN/A

NORCOM INFORMATION TECHNOLOG / NC5A.DE FAQ

What is the ChartMill fundamental rating of NORCOM INFORMATION TECHNOLOG (NC5A.DE) stock?

ChartMill assigns a fundamental rating of 1 / 10 to NC5A.DE.

What is the valuation status for NC5A stock?

ChartMill assigns a valuation rating of 0 / 10 to NORCOM INFORMATION TECHNOLOG (NC5A.DE). This can be considered as Overvalued.

What is the profitability of NC5A stock?

NORCOM INFORMATION TECHNOLOG (NC5A.DE) has a profitability rating of 1 / 10.

Can you provide the financial health for NC5A stock?

The financial health rating of NORCOM INFORMATION TECHNOLOG (NC5A.DE) is 2 / 10.

NORCOM INFORMATION TECHNOLOG (NC5A.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

NORCOM INFORMATION TECHNOLOG / NC5A.DE FAQ

What is the ChartMill fundamental rating of NORCOM INFORMATION TECHNOLOG (NC5A.DE) stock?

What is the valuation status for NC5A stock?

What is the profitability of NC5A stock?

Can you provide the financial health for NC5A stock?